Literature DB >> 16943668

Alpha-II-spectrin after controlled cortical impact in the immature rat brain.

J Aikman1, B O'Steen, X Silver, R Torres, S Boslaugh, S Blackband, K Padgett, K K W Wang, R Hayes, J Pineda.   

Abstract

Proteolytic processing plays an important role in regulating a wide range of important cellular functions, including processing of cytoskeletal proteins. Loss of cytoskeletal proteins such as spectrin is an important characteristic in a variety of acute central nervous system injuries including ischemia, spinal cord injury and traumatic brain injury (TBI). The literature contains extensive information on the proteolytic degradation of alpha-II-spectrin after TBI in the adult brain. By contrast, there is limited knowledge on the characteristics and relevance of these important processes in the immature brain. The present experiments examine TBI-induced proteolytic processing of alpha-II-spectrin after TBI in the immature rat brain. Distinct proteolytic products resulting from the degradation of the cytoskeletal protein alpha-II-spectrin by calpain and caspase 3 were readily detectable in cortical brain parenchyma and cerebrospinal fluid after TBI in immature rats. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943668     DOI: 10.1159/000094171

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  13 in total

1.  Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury.

Authors:  Ayman G Mustafa; Juan A Wang; Kimberly M Carrico; Edward D Hall
Journal:  J Neurochem       Date:  2011-03-22       Impact factor: 5.372

Review 2.  Therapeutic strategies to target acute and long-term sequelae of pediatric traumatic brain injury.

Authors:  Jimmy W Huh; Ramesh Raghupathi
Journal:  Neuropharmacology       Date:  2018-06-20       Impact factor: 5.250

3.  Alpha II Spectrin breakdown products in immature Sprague Dawley rat hippocampus and cortex after traumatic brain injury.

Authors:  Michelle E Schober; Daniela F Requena; Lizeth J Davis; Ryan R Metzger; Kimberly S Bennett; Denise Morita; Christian Niedzwecki; Zhihui Yang; Kevin K W Wang
Journal:  Brain Res       Date:  2014-06-12       Impact factor: 3.252

4.  Detection of alpha II-spectrin breakdown products in the serum of neonates with congenital heart disease*.

Authors:  Parag Jain; Michael C Spaeder; Mary T Donofrio; Pranava Sinha; Richard A Jonas; Richard J Levy
Journal:  Pediatr Crit Care Med       Date:  2014-03       Impact factor: 3.624

Review 5.  Quo vadis 2010? - carpe diem: challenges and opportunities in pediatric traumatic brain injury.

Authors:  Patrick M Kochanek; Michael J Bell; Hülya Bayır
Journal:  Dev Neurosci       Date:  2011-01-21       Impact factor: 2.984

6.  Proteolysis of submembrane cytoskeletal proteins ankyrin-G and αII-spectrin following diffuse brain injury: a role in white matter vulnerability at Nodes of Ranvier.

Authors:  Thomas M Reeves; John E Greer; Andrew S Vanderveer; Linda L Phillips
Journal:  Brain Pathol       Date:  2010-06-15       Impact factor: 6.508

Review 7.  Calpain as a therapeutic target in traumatic brain injury.

Authors:  Kathryn E Saatman; Jennifer Creed; Ramesh Raghupathi
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

8.  Hypobaric hypoxia and reoxygenation induce proteomic profile changes in the rat brain cortex.

Authors:  Raquel Hernández; Santos Blanco; Juan Peragón; Juan Á Pedrosa; María Á Peinado
Journal:  Neuromolecular Med       Date:  2012-09-08       Impact factor: 3.843

9.  Biochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion.

Authors:  Melissa J McGinn; Brian J Kelley; Linnet Akinyi; Monika W Oli; Ming Cheng Liu; Ronald L Hayes; Kevin K W Wang; John T Povlishock
Journal:  J Neuropathol Exp Neurol       Date:  2009-03       Impact factor: 3.685

10.  Calpastatin overexpression limits calpain-mediated proteolysis and behavioral deficits following traumatic brain injury.

Authors:  Kathleen M Schoch; Heather N Evans; Jennifer M Brelsfoard; Sindhu K Madathil; Jiro Takano; Takaomi C Saido; Kathryn E Saatman
Journal:  Exp Neurol       Date:  2012-05-01       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.